Cargando…
Safety and Efficacy of Efpeglenatide in Patients With Type 2 Diabetes: A Meta-Analysis of Randomized Controlled Trials
The aim of this study was to assess the efficacy and safety of efpeglenatide in patients with type 2 diabetes (T2D). The study was reported according to the 2020 guidelines of the Preferred Reporting Items for Systematic Reviews and Meta-analyses (PRISMA) statement. Web of Science, PubMed, and Scopu...
Autores principales: | Escobar, Johao, Monday, Obinna, Vemoori, Yashwanth, Yadav, Indresh, Maslamani, Abdalkareem Nael Jameel, Al Kutabi, Salem, Saeed, Leena, Khan, Areeba |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Cureus
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10599090/ https://www.ncbi.nlm.nih.gov/pubmed/37885518 http://dx.doi.org/10.7759/cureus.45927 |
Ejemplares similares
-
Efficacy and Safety of Once-Weekly Efpeglenatide Monotherapy Versus Placebo in Type 2 Diabetes: The AMPLITUDE-M Randomized Controlled Trial
por: Frias, Juan Pablo, et al.
Publicado: (2022) -
Pharmacokinetic and dose‐finding studies on efpeglenatide in patients with type 2 diabetes
por: Yoon, Kun‐Ho, et al.
Publicado: (2020) -
Body weight management and safety with efpeglenatide in adults without diabetes: A phase II randomized study
por: Pratley, Richard E., et al.
Publicado: (2019) -
Efficacy and safety of efpeglenatide in key patient subgroups from the BALANCE randomized trial, stratified by pre-diabetes status, BMI, and age at baseline
por: Pratley, Richard E, et al.
Publicado: (2022) -
Comparison of the Effectiveness of Prolonged Infusion and Intermittent Infusion of Meropenem in Patients With Sepsis: A Meta-Analysis
por: Lokhandwala, Adnan, et al.
Publicado: (2023)